Document is current
Any future updates will be listed below
-
Authors
Nyemba, Dorothy Chiwoniso
de Voux, Alex
Mvududu, Rufaro
Peters, Remco P. H.
Delany-Moretlwe, Sinead
Johnson, Leigh F.
Coates, Thomas J.
Myer, Landon
Davey, Dvora Leah Joseph
-
Funding
Funding for this research was provided by:
National Institute of Mental Health and Fogarty International (R01MH116771 and K01TW011187)
- License Information
-
More Information
Article History
Received: 22 December 2025
Accepted: 1 July 2026
First Online: 21 July 2026
Declarations
Ethical approval and consent to participate: Ethical approvals were provided by the Institutional Review Boards at the University of Cape Town’s Faculty of Health Sciences Research Ethics Committee (UCT-HREC, reference number 297/2018), and the University of California Los Angeles (reference number 18-001622). All women participating in the study provided informed written consent for their own participation and that of their infant’s. All methods in this study were carried out in accordance with relevant guidelines and regulations in the Helsinki Declaration as revised in 1983.
Consent for publication: Not applicable.
Competing interests: The study drug for HIV prevention (oral PrEP), Truvada, was donated by Gilead, and STI test kits (GeneXpert) were donated by Cepheid.
